Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Ferroportin Downregulation Promotes Cell Proliferation By Modulating the Nrf2-Mir 17-5p Axis in Multiple Myeloma

Jumei Shi, MD, Yuanyuan Kong, PhD, Liangning Hu, Gege Chen, Dandan Yu, Yongsheng Xie, Yingcong Wang, Xiaosong Wu

Blood (2019) 134 (Supplement_1): 5596.

https://doi.org/10.1182/blood-2019-131679

Published: 2019

Journal Articles

Rafoxanide, an Organohalogen Drug, Triggers Apoptosis and Cell Cycle Arrest in Multiple Myeloma By Enhancing DNA Damage Responses and Suppressing the p38 MAPK Pathway

Jumei Shi, Wenqin Xiao, Zhijian Xu, Shuaikang Chang, Lu Gao, Yi Tao, Yingcong Wang, Xiaosong Wu, Weiliang Zhu

Blood (2018) 132 (Supplement 1): 5628.

https://doi.org/10.1182/blood-2018-99-113782

Published: 2018

Journal Articles

Carfilzomib Enhances Natural Killer Cell-Mediated Lysis of Myeloma Linked with Decreasing Expression of HLA Class I

Jumei Shi, MD, PhD, Guang Yang, Yuanyuan Kong, Minjie Gao, Yi Tao, Yiwen Zhang, Xiaosong Wu

Blood (2015) 126 (23): 1854.

https://doi.org/10.1182/blood.V126.23.1854.1854

Published: 2015

Journal Articles

Valproic Acid Upregulates NKG2D Ligand Expression and Potentially Enhances Natural Killer Cell–mediated Cytolysis of Myeloma

Jumei Shi, MD, PhD, Yi Tao, Xiaosong Wu, Xiaojing Hu, Yang Shao, Jun Hou

Blood (2011) 118 (21): 5061.

https://doi.org/10.1182/blood.V118.21.5061.5061

Published: 2011

Journal Articles

Identification of early growth response protein 1 ( EGR-1 ) as a novel target for JUN -induced apoptosis in multiple myeloma

Lijuan Chen, Siqing Wang, Yiming Zhou, Xiaosong Wu, Igor Entin, Joshua Epstein, Shmuel Yaccoby, Wei Xiong, Bart Barlogie, John D. Shaughnessy, Jr, Fenghuang Zhan

Blood (2010) 115 (1): 61–70.

https://doi.org/10.1182/blood-2009-03-210526

Published: 2010

Journal Articles

High-Risk Multiple Myeloma Is Characterized by Uniform Over-Expression of Mirnas and Increased Copy Number and Expression of Argonaute 2 , A Master Regulator of Mirna Maturation and B-Cell Development.

Yiming Zhou, Lijuan Chen, Bart Barlogie, MD, PhD, Owen Stephens, PhD, Xiaosong Wu, PhD, David Williams, PhD, Marie-astrid Cartron, PhD, Frits van Rhee, MD, PhD, Bijay Nair, MD, Sarah Waheed, MD, Mauricio Pineda-Roman, MD, PhD, Yazan Alsayed, MD, PhD, Elias Anaissie, MD, PhD, John D Shaughnessy, Jr.

Blood (2009) 114 (22): 1804.

https://doi.org/10.1182/blood.V114.22.1804.1804

Published: 2009

Journal Articles

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma

Wei Xiong, Xiaosong Wu, Sarah Starnes, Sarah K. Johnson, Jeff Haessler, Siqing Wang, Lijuan Chen, Bart Barlogie, John D. Shaughnessy, Jr, Fenghuang Zhan

Blood (2008) 112 (10): 4235–4246.

https://doi.org/10.1182/blood-2007-10-119123

Published: 2008

Includes: Supplemental data

Journal Articles

CKS1B , overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27 Kip1 -dependent and -independent mechanisms

Fenghuang Zhan, Simona Colla, Xiaosong Wu, Bangzheng Chen, James P. Stewart, W. Michael Kuehl, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2007) 109 (11): 4995–5001.

https://doi.org/10.1182/blood-2006-07-038703

Published: 2007

Journal Articles

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

Simona Colla, Fenghuang Zhan, Wei Xiong, Xiaosong Wu, Hongwei Xu, Owen Stephens, Shmuel Yaccoby, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2007) 109 (10): 4470–4477.

https://doi.org/10.1182/blood-2006-11-056747

Published: 2007

Journal Articles

CKS1B, Mapping to an Amplicon on Chromosome 1q21 and over Expressed in Aggressive Disease, Regulates Multiple Myeloma Growth and Survival through p27 Kip1 -Dependent and Independent Mechanisms.

Fenghuang Zhan, Simona Colla, James B. Chen, James P. Stewart, Xiaosong Wu, Yongsheng Huang, Ichiro Hanamura, Bart Burington, Shmuel Yaccoby, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3408.

https://doi.org/10.1182/blood.V108.11.3408.3408

Published: 2006

NARROW

Ferroportin Downregulation Promotes Cell Proliferation By Modulating the Nrf2-Mir 17-5p Axis in Multiple Myeloma

Rafoxanide, an Organohalogen Drug, Triggers Apoptosis and Cell Cycle Arrest in Multiple Myeloma By Enhancing DNA Damage Responses and Suppressing the p38 MAPK Pathway

Carfilzomib Enhances Natural Killer Cell-Mediated Lysis of Myeloma Linked with Decreasing Expression of HLA Class I

Valproic Acid Upregulates NKG2D Ligand Expression and Potentially Enhances Natural Killer Cell–mediated Cytolysis of Myeloma

Identification of early growth response protein 1 ( EGR-1 ) as a novel target for JUN -induced apoptosis in multiple myeloma

High-Risk Multiple Myeloma Is Characterized by Uniform Over-Expression of Mirnas and Increased Copy Number and Expression of Argonaute 2 , A Master Regulator of Mirna Maturation and B-Cell Development.

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma

CKS1B , overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27 Kip1 -dependent and -independent mechanisms

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

CKS1B, Mapping to an Amplicon on Chromosome 1q21 and over Expressed in Aggressive Disease, Regulates Multiple Myeloma Growth and Survival through p27 Kip1 -Dependent and Independent Mechanisms.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only